About eXoZymes Inc. (EXOZ)
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
EXOZ Key Statistics
| Current Price | $7.53 | Market Cap | $63 million |
|---|---|---|---|
| Daily Change | +6.14% | Volume | 1K |
| 52-Week High | $18.40 | 52-Week Low | $7.08 |
| Sector | Healthcare | Industry | Biotechnology |
EXOZ Price Performance
eXoZymes Inc. stock has returned +6.21% over the past day, -15.39% over the past week, -24.70% over the past month, and -26.18% over the past three months. The stock trades between a 52-week low of $7.08 and a high of $18.40.
EXOZ Financial Fundamentals
eXoZymes Inc. reports a return on equity (ROE) of -940.69%. The debt-to-equity ratio is 0.25. Current ratio stands at 4.53.
EXOZ Ownership
Institutional investors hold approximately +0.01% of EXOZ shares across 7 institutions. Insider ownership is +0.72%. Insider sentiment is "neutral".